In vivo-applied functional RNAs as tools in proteomics and genomics research

Trends in Biotechnology

Volumn 20, Issue 11, 2002, Pages 462-466

  Famulok, Michael ^a   Verma, Sandeep ^b  

^a UNIVERSITY OF BONN   (Germany)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; PROTEINS; RNA;

GENOMICS;

BIOTECHNOLOGY;

HELICASE; LAMIN A; LAMIN C; NUCLEIC ACID; RIBOZYME; RNA;

BIOTECHNOLOGY; GENOME;

CATALYSIS; GENE EXPRESSION; GENE FUNCTION; GENOMICS; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW;

ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENOMICS; HUMANS; LIGANDS; PROTEIN ENGINEERING; PROTEOMICS; RIBOSOMAL PROTEINS; RNA; RNA, SMALL INTERFERING;

EID: 0036843787     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(02)02063-2     Document Type: Review

References (36)

1. Kuwabara T., et al. Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity. Trends Biotechnol. 18:2000;462-468.
2. Branch A.D. A good antisense molecule is hard to find. Trends Biochem. Sci. 23:1998;45-50.
3. Rossi J.J. Ribozymes, genomics and therapeutics. Chem. Biol. 6:1999;R33-R37.
4. Rossi J.J. Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends Biotechnol. 13:1995;301-306.
5. Bramlage B., et al. Designing ribozymes for the inhibition of gene expression. Trends Biotechnol. 16:1998;434-438.
6. Samarsky D., et al. Expressing active ribozymes in cells. Curr. Issues Mol. Biol. 2:2000;87-93.
7. Warashina M., et al. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5572-5577.
8. Kawasaki H., et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature. 393:1998;284-289.
9. Kawasaki H., Taira K. Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogenous RNA helicase. EMBO Rep. 3:2002;443-450.
10. Kawasaki H., et al. Identification of genes that function in the TNF-(-mediated apoptotic pathway using randomized hybrid ribozyme libraries. Nat. Biotechnol. 20:2002;376-380.
11. Elbashir S.M., et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:2001;188-200.
12. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
13. Tuschl T. RNA interference and small interfering RNAs. Chembiochem. 2:2001;239-245.
14. Brummelkamp T.R., et al. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
15. Paul C.P., et al. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
16. Paddison P.J., et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:2002;948-958.
17. Yu J.Y., et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6047-6052.
18. Tuschl T. Expanding small RNA interference. Nat. Biotechnol. 20:2002;446-448.
19. Lee N.S., et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:2002;500-505.
20. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:2002;497-500.
21. McManus M.T., et al. Gene silencing using micro-RNA designed hairpins. RNA. 8:2002;842-850.
22. Sui G., et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5515-5520.
23. Zeng Y., et al. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell. 9:2002;1327-1333.
24. Famulok M., et al. Intramers as promising new tools in functional proteomics. Chem. Biol. 8:2001;931-939.
25. Good P.D., et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4:1997;45-54.
26. Konopka K., et al. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication. Gene. 255:2000;235-244.
27. Thomas M., et al. Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers. J. Biol. Chem. 272:1997;27980-27986.
28. Shi H., et al. RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10033-10038.
29. Blind M., et al. Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3606-3610.
30. Kolanus W., Zeitlmann L. Regulation of integrin function by inside-out signaling mechanisms. Curr. Top. Microbiol. Immunol. 231:1998;33-49.
31. Mayer G., et al. Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4961-4965.
32. Jackson C.L., Casanova J.E. Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol. 10:2000;60-67.
33. Hamm J., et al. Anti-idiotype RNA selected with an anti-nuclear export signal antibody is actively transported in oocytes and inhibits Rev- and cap-dependent RNA export. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12839-12844.
34. Hamm J., Fornerod M. Anti-idiotype RNAs that mimic the leucine-rich nuclear export signal and specifically bind to CRM1/exportin 1. Chem. Biol. 7:2000;345-354.
35. Grimm C., et al. Selection and nuclear immobilization of exportable RNAs. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10122-10127.
36. Gwizdek C., et al. Terminal minihelix, a novel RNA motif that directs polymerase III transcripts to the cell cytoplasm. Terminal minihelix and RNA export. J. Biol. Chem. 276:2001;25910-25918.